Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Rowley Law PLLC is investigating potential claims against Osiris Therapeutics, Inc. (NASDAQ: OSIR) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Smith & Nephew plc. Stockholders will receive $19.00 for each share of Osiris Therapeutics, Inc. stock that they hold. The transaction is valued at approximately $660.5 million and is expected to close in the second quarter of 2019.rter of 2019.

If you are an Osiris Therapeutics, Inc. stockholder and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Request Information

The submission of this form does not create an attorney-client relationship.

2019-05-17T15:44:18+00:00